We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $21.7B
1-Year Est. Return 79.24%
This Fund
S&P 500
This Quarter Est. Return
-0.07%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$19.1B
AUM Growth
-$4.04B
Cap. Flow
-$3.24B
Cap. Flow %
-16.98%
Top 10 Hldgs %
50.33%
Holding
204
New
48
Increased
30
Reduced
30
Closed
31

Top Buys

Rank Stock Value
1
EA
Electronic Arts
EA
+$492M
2
AVGO icon
Broadcom
AVGO
+$292M
3
KKR icon
KKR & Co
KKR
+$280M
4
ROIV icon
Roivant Sciences
ROIV
+$248M
5
MA icon
Mastercard
MA
+$138M

Top Sells

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$650M
2
CYBR
CyberArk
CYBR
+$470M
3
CRM icon
Salesforce
CRM
+$334M
4
NDAQ icon
Nasdaq
NDAQ
+$290M
5
RNAM
Avidity Biosciences
RNAM
+$233M

Sector Composition

Rank Sector Weight
1 Healthcare 46.53%
2 Communication Services 11.31%
3 Financials 11.23%
4 Technology 10.28%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EA
1
DELISTED
Electronic Arts
EA
$1.52B 7.99%
7,470,000
+2,435,000
+48% +$492M
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$813B
$1.5B 7.85%
2,300,000
-700,000
-23% -$476M
RVMD icon
3
Revolution Medicines
RVMD
$43.7B
$1.32B 6.94%
13,604,796
-978,000
-7% -$98.8M
AMZN icon
4
Amazon
AMZN
$2.83T
$879M 4.61%
4,218,394
-281,500
-6% -$62M
MSFT icon
5
Microsoft
MSFT
$3.68T
$868M 4.55%
2,344,779
+130,700
+6% +$54.7M
AON icon
6
Aon
AON
$75.5B
$811M 4.25%
2,512,638
-152,600
-6% -$50.7M
BBIO icon
7
BridgeBio Pharma
BBIO
$15.6B
$695M 3.65%
9,365,463
+367,000
+4% +$26.6M
PPA icon
8
PUT
Invesco Aerospace & Defense ETF
PPA
$8.77B
$691M 3.62%
+3,600,000
New +$629M
PTGX icon
9
Protagonist Therapeutics
PTGX
$10B
$669M 3.51%
6,348,906
+204,900
+3% +$18.1M
NTRA icon
10
Natera
NTRA
$44.7B
$641M 3.36%
3,207,366
-707,000
-18% -$152M
EXEL icon
11
Exelixis
EXEL
$12.7B
$562M 2.95%
13,111,010
-2,598,490
-17% -$112M
AVGO icon
12
Broadcom
AVGO
$1.87T
$551M 2.89%
1,779,500
+887,100
+99% +$292M
UNH icon
13
UnitedHealth
UNH
$361B
$493M 2.59%
1,821,706
+222,800
+14% +$66.4M
SNPS icon
14
Synopsys
SNPS
$80.7B
$481M 2.52%
1,213,300
+214,100
+21% +$96.8M
BSX icon
15
Boston Scientific
BSX
$75.1B
$469M 2.46%
7,470,684
+31,120
+0.4% +$2.49M
TMO icon
16
Thermo Fisher Scientific
TMO
$218B
$433M 2.27%
881,485
+245,800
+39% +$133M
KKR icon
17
KKR & Co
KKR
$102B
$432M 2.27%
4,671,800
+2,654,100
+132% +$280M
LNTH icon
18
Lantheus
LNTH
$6.59B
$424M 2.22%
5,583,479
+156,000
+3% +$11.2M
WAB icon
19
Wabtec
WAB
$50.5B
$402M 2.11%
1,609,403
-866,600
-35% -$210M
SCHW
20
Charles Schwab
SCHW
$192B
$372M 1.95%
3,955,657
+616,000
+18% +$60.4M
LQDA icon
21
Liquidia Corp
LQDA
$6.66B
$327M 1.71%
8,656,038
– –
CRNX icon
22
Crinetics Pharmaceuticals
CRNX
$8.99B
$303M 1.59%
8,338,098
+1,405,000
+20% +$62.8M
GOOG icon
23
Alphabet (Google) Class C
GOOG
$4.2T
$286M 1.5%
996,231
+209,191
+27% +$65.7M
ROIV icon
24
Roivant Sciences
ROIV
$26.1B
$268M 1.41%
9,675,000
+9,638,000
+26,049% +$248M
V icon
25
Visa
V
$680B
$254M 1.33%
840,710
+144,800
+21% +$46.6M
1
2 3 4 5

Similar funds

VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return

Farallon Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Farallon Capital Management held 204 positions worth $19.1B, down 17% from $23.1B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Farallon Capital Management withdrew a net $3.24B in Q1 2026, closing 31 positions and reducing 30 holdings. Its most notable exit was Exact Sciences, an estimated $650M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 41% a quarter earlier, followed by Communication Services and Financials.

Against the trend, Farallon Capital Management opened a new position in Dianthus Therapeutics worth $70.2M.

  • Farallon Capital Management's largest Q1 2026 buy was Dianthus Therapeutics: 836,000 shares worth $70.2M.
  • Farallon Capital Management added most to Electronic Arts in Q1 2026, an estimated $492M increase.
  • Farallon Capital Management's biggest Q1 2026 reduction was Wabtec, cutting an estimated $210M.
  • Farallon Capital Management fully exited Exact Sciences in Q1 2026, selling an estimated $650M.
  • Farallon Capital Management's ten largest holdings make up 50% of its $19.1B portfolio in Q1 2026.
  • Farallon Capital Management opened 48 new positions and closed 31 in Q1 2026.
  • Farallon Capital Management's portfolio value fell 17% quarter-over-quarter to $19.1B.

Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.